Health Canada approves Medison and Ipsen’s Bylvay to treat ALGS
The approval is backed by the placebo-controlled, randomised and double-blind Phase III ASSERT trial.
Approvals
Health Canada approves AbbVie’s Elahere for ovarian cancer
FDA approves Sanofi’s BTK inhibitor for immune thrombocytopenia
Health Canada issues NOC to AbbVie’s upadacitinib for giant cell arteritis
MHRA approves GSK’s oral antibiotic for UTIs in females
ExCellThera gains EC authorisation for Zemcelpro cell therapy
FDA approves Ionis’ donidalorsen for HAE attack prevention
FDA approves Tonix’s Tonmya to treat fibromyalgia
